It is noteworthy that the only patient for whom we could not detect ESO expression in the breast tumor (that at variance with the others was low grade, ER+) was diagnosed with malignant melanoma, that frequently expresses ESO, a few months after the diagnosis of BC. This evidence concerns the gene ESR1 and breast cancer.